COM:ALEMBICPHARMACEUTICALS
Alembic Pharmaceuticals
- Stock
Last Close
1,041.85
25/11 09:40
Market Cap
196.41B
Beta: -
Volume Today
140.60K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.89B - | 3.47B 20.07% | 4.80B 38.47% | 6.05B 26.03% | 6.83B 12.92% | 8.51B 24.48% | 10.77B 26.66% | 13.37B 24.08% | 15.48B 15.79% | 15.42B 0.35% | 15.59B 1.10% | |
average payables | 7.20M - | 9.23M 28.25% | 9.21M 0.18% | 10.15M 10.14% | 6.75M 33.49% | 26.45M 291.85% | 3.16B 11,828.54% | 6.47B 105.18% | 6.88B 6.21% | 6.93B 0.80% | 7.08B 2.11% | |
average receivables | 2.39B - | 5.07B 111.94% | 6.31B 24.54% | 6.71B 6.34% | 9.09B 35.51% | 10.05B 10.53% | 9.98B 0.66% | 11.60B 16.15% | 10.36B 10.69% | |||
book value per share | 35.83 - | 46.93 30.99% | 84.90 80.90% | 100.85 18.78% | 117.77 16.78% | 144.22 22.46% | 170.78 18.41% | 264.66 54.98% | 266.46 0.68% | 222.34 16.56% | 245.13 10.25% | |
capex per share | -4.35 - | -11.86 172.88% | -16.11 35.78% | -24.95 54.93% | -43.59 74.70% | -40.55 6.98% | -38.98 3.86% | -34.04 12.68% | -21.65 36.39% | -22.56 4.17% | 16.66 173.85% | |
capex to depreciation | -2.02 - | -5.03 148.67% | -4.20 16.48% | -5.67 34.84% | -7.79 37.44% | -6.63 14.87% | -4.67 29.58% | -3.59 23.05% | -1.48 58.71% | -1.61 8.47% | 1.20 174.60% | |
capex to operating cash flow | -0.35 - | -1.30 275.16% | -0.33 74.93% | -1.63 399.11% | -2.63 61.49% | -0.94 64.21% | -1.64 73.81% | -0.45 72.46% | -0.77 70.99% | -0.61 20.52% | 0.41 166.57% | |
capex to revenue | -0.05 - | -0.11 147.02% | -0.10 10.66% | -0.16 56.20% | -0.27 74.41% | -0.20 25.84% | -0.16 18.52% | -0.12 23.60% | -0.08 34.91% | -0.08 3.58% | 0.05 167.02% | |
cash per share | 1.27 - | 1.42 11.99% | 23.91 1,580.37% | 8.12 66.04% | 5.09 37.33% | 10.56 107.52% | 3.81 63.91% | 14.71 286.06% | 4.72 67.94% | 4.69 0.64% | 6.12 30.50% | |
days of inventory on hand | 149.42 - | 184.25 23.31% | 250.21 35.79% | 222.66 11.01% | 252.21 13.28% | 295.84 17.30% | 329.84 11.49% | 356.57 8.10% | 340.96 4.38% | 315.11 7.58% | 151.50 51.92% | |
days payables outstanding | 0.42 - | 0.46 9.20% | 0.38 17.80% | 0.40 6.18% | 0.07 83.02% | 1.56 2,165.10% | 173.85 11,067.48% | 160.46 7.71% | 149.63 6.75% | 145.21 2.95% | 67.81 53.30% | |
days sales outstanding | 57.13 - | 64.47 12.86% | 87.41 35.57% | 58.99 32.51% | 97.78 65.74% | 55.81 42.92% | 83.02 48.76% | 72.91 12.18% | 60.06 17.63% | |||
debt to assets | 0.09 - | 0.16 78.73% | 0.06 60.39% | 0.03 48.20% | 0.18 445.08% | 0.24 31.51% | 0.31 29.42% | 0.09 71.54% | 0.10 15.75% | 0.12 15.98% | 0.07 42.81% | |
debt to equity | 0.16 - | 0.30 83.94% | 0.10 67.19% | 0.05 52.36% | 0.32 584.67% | 0.42 30.19% | 0.57 37.01% | 0.11 79.98% | 0.14 20.30% | 0.17 20.66% | 0.09 45.92% | |
dividend yield | 0.01 - | 0.01 24.73% | 0.01 24.30% | 0.01 31.65% | 0.01 16.17% | 0.01 0.57% | 0.03 263.66% | 0.02 - | 0.02 6.72% | 0.01 60.64% | ||
earnings yield | 0.04 - | 0.03 24.65% | 0.06 93.15% | 0.03 46.55% | 0.04 18.04% | 0.06 42.20% | 0.08 43.85% | 0.06 23.42% | 0.04 43.29% | 0.04 1.91% | 0.03 11.41% | |
enterprise value | 54.60B - | 88.05B 61.26% | 109.86B 24.77% | 117.64B 7.08% | 108.80B 7.51% | 111.44B 2.43% | 118.30B 6.16% | 191.81B 62.13% | 152.33B 20.58% | 104.03B 31.71% | 202.25B 94.41% | |
enterprise value over ebitda | 15.20 - | 21.64 42.44% | 10.87 49.77% | 19.17 76.29% | 16.88 11.93% | 12.45 26.24% | 9.66 22.42% | 12.30 27.34% | 16.46 33.81% | 15.29 7.08% | 21.03 37.51% | |
ev to operating cash flow | 23.12 - | 51.27 121.79% | 11.81 76.97% | 40.73 244.96% | 34.83 14.50% | 13.72 60.59% | 26.34 91.92% | 13.11 50.24% | 27.58 110.41% | 14.37 47.90% | 25.18 75.23% | |
ev to sales | 3.00 - | 4.38 46.03% | 3.60 17.91% | 3.88 7.96% | 3.58 7.66% | 2.93 18.34% | 2.63 10.04% | 3.64 38.03% | 2.91 19.91% | 1.84 36.79% | 3.25 76.44% | |
free cash flow per share | 8.18 - | -2.75 133.61% | 33.25 1,309.30% | -9.63 128.97% | -27.02 180.50% | 2.52 109.34% | -15.16 700.48% | 41.49 373.71% | 6.45 84.46% | 14.27 121.40% | 24.20 69.58% | |
free cash flow yield | 0.03 - | -0.01 121.07% | 0.06 1,018.69% | -0.02 127.63% | -0.05 223.50% | 0.00 109.38% | -0.03 709.03% | 0.04 251.54% | 0.01 79.78% | 0.03 230.80% | 0.02 16.58% | |
graham net net | -19.25 - | -28.56 48.40% | 12.70 144.46% | 4.53 64.32% | -37.80 934.18% | -48.57 28.49% | -65.27 34.39% | -0.46 99.30% | -4.80 950.60% | -6.91 43.81% | 4.23 161.30% | |
graham number | 100.34 - | 125.90 25.47% | 270.01 114.46% | 220.29 18.41% | 240.83 9.33% | 317.16 31.69% | 411.02 29.59% | 601.76 46.41% | 398.61 33.76% | 295.03 25.99% | 415.69 40.90% | |
income quality | 0.76 - | 0.48 37.10% | 0.99 107.89% | 0.55 44.72% | 0.58 5.00% | 1.08 87.73% | 0.45 58.54% | 1.07 138.12% | 0.89 16.73% | 2.04 129.21% | 1.30 36.12% | |
intangibles to total assets | 0 - | 0.02 Infinity% | 0.02 17.61% | 0.01 43.26% | 0.04 318.47% | 0.06 34.31% | 0.05 11.61% | 0.05 3.59% | 0.02 54.84% | -0.01 159.29% | 0 100% | |
interest coverage | 30.86 - | 92.75 200.52% | 218.98 136.09% | 105.31 51.91% | 149.96 42.39% | 41.14 72.56% | 39.30 4.47% | 85.88 118.52% | 36.03 58.05% | 8.07 77.61% | 10.25 27.02% | |
interest debt per share | 6.35 - | 14.18 123.21% | 8.52 39.89% | 4.97 41.73% | 37.73 659.48% | 60.84 61.26% | 98.55 62.00% | 30.95 68.59% | 37.38 20.79% | 39.28 5.08% | 24.76 36.98% | |
inventory turnover | 2.44 - | 1.98 18.90% | 1.46 26.36% | 1.64 12.37% | 1.45 11.72% | 1.23 14.75% | 1.11 10.31% | 1.02 7.50% | 1.07 4.58% | 1.16 8.20% | 2.41 108.00% | |
invested capital | 0.16 - | 0.30 83.94% | 0.10 67.19% | 0.05 52.36% | 0.32 584.67% | 0.42 30.19% | 0.57 37.01% | 0.11 79.98% | 0.14 20.30% | 0.17 20.66% | 46.95B 28,417,013,609,910.80% | |
market cap | 53.75B - | 85.69B 59.42% | 112.81B 31.65% | 118.28B 4.85% | 102.56B 13.29% | 102.15B 0.40% | 100.71B 1.40% | 186.95B 85.62% | 145.77B 22.03% | 97.56B 33.07% | 198.32B 103.27% | |
net current asset value | 2.13B - | 1.34B 36.97% | 6.48B 382.62% | 5.36B 17.31% | 1.04B 80.55% | -1.02B 197.94% | -3.36B 229.26% | 9.36B 378.66% | 9.76B 4.32% | 10.98B 12.43% | 14.51B 32.21% | |
net debt to ebitda | 0.24 - | 0.58 144.68% | -0.29 150.08% | -0.11 63.90% | 0.97 1,020.40% | 1.04 7.25% | 1.44 38.31% | 0.31 78.32% | 0.71 127.63% | 0.95 34.10% | 0.41 57.01% | |
net income per share | 12.49 - | 15.01 20.18% | 38.16 154.25% | 21.39 43.96% | 21.89 2.35% | 31.00 41.62% | 43.97 41.83% | 60.81 38.31% | 26.50 56.42% | 17.40 34.35% | 31.33 80.07% | |
operating cash flow per share | 12.53 - | 9.11 27.26% | 49.35 441.61% | 15.32 68.96% | 16.57 8.18% | 43.07 159.89% | 23.82 44.69% | 75.53 217.04% | 28.10 62.80% | 36.83 31.07% | 40.86 10.95% | |
payables turnover | 859.64 - | 787.22 8.42% | 957.68 21.65% | 901.97 5.82% | 5.31K 488.78% | 234.46 95.59% | 2.10 99.10% | 2.27 8.35% | 2.44 7.24% | 2.51 3.04% | 5.38 114.14% | |
receivables turnover | 6.39 - | 5.66 11.39% | 4.18 26.24% | 6.19 48.16% | 3.73 39.67% | 6.54 75.21% | 4.40 32.78% | 5.01 13.87% | 6.08 21.40% | |||
research and ddevelopement to revenue | 0.06 - | 0.06 5.41% | 0.10 66.11% | 0.03 67.76% | 0.01 62.53% | 0.01 34.52% | 0.01 19.37% | 0.00 49.33% | 0.01 101.02% | 0.01 46.82% | 0.07 1,269.12% | |
return on tangible assets | 0.19 - | 0.18 8.90% | 0.30 69.03% | 0.15 49.10% | 0.11 27.90% | 0.13 18.61% | 0.15 12.37% | 0.18 26.65% | 0.07 59.47% | 0.05 26.96% | 0.10 74.96% | |
revenue per share | 96.53 - | 106.63 10.47% | 162.05 51.97% | 160.73 0.82% | 161.00 0.16% | 201.93 25.42% | 238.28 18.00% | 272.33 14.29% | 266.16 2.27% | 287.57 8.04% | 316.88 10.19% | |
roe | 0.35 - | 0.32 8.26% | 0.45 40.55% | 0.21 52.82% | 0.19 12.36% | 0.21 15.65% | 0.26 19.78% | 0.23 10.75% | 0.10 56.71% | 0.08 21.33% | 0.13 63.34% | |
roic | 0.31 - | 0.24 21.88% | 0.41 69.12% | 0.21 49.23% | 0.14 34.89% | 0.16 14.97% | 0.17 6.96% | 0.19 16.18% | 0.09 54.56% | 0.08 14.26% | 0.11 41.85% | |
sales general and administrative to revenue | 0.02 - | 0.02 15.53% | 0.02 19.63% | 0.05 182.32% | 0.04 24.06% | 0.04 2.28% | 0.03 2.68% | 0.04 14.52% | 0.04 1.97% | 0.04 5.75% | 0.04 5.14% | |
shareholders equity per share | 35.83 - | 46.93 30.99% | 84.90 80.90% | 100.85 18.78% | 117.77 16.78% | 144.22 22.46% | 170.78 18.41% | 264.66 54.98% | 266.46 0.68% | 222.34 16.56% | 245.13 10.25% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | 6.76B - | 8.49B 25.72% | 15.57B 83.31% | 18.74B 20.38% | 20.55B 9.63% | 24.48B 19.15% | 28.91B 18.11% | 47.44B 64.07% | 50.83B 7.14% | 44.50B 12.45% | 48.18B 8.27% | |
tangible book value per share | 35.83 - | 45.06 25.77% | 82.59 83.29% | 99.42 20.38% | 108.99 9.63% | 129.86 19.15% | 153.38 18.11% | 244.86 59.65% | 258.58 5.60% | 222.34 14.01% | 245.13 10.25% | |
working capital | 3.07B - | 2.07B 32.75% | 7.39B 257.68% | 6.42B 13.10% | 7.01B 9.18% | 4.68B 33.25% | 7.11B 51.92% | 12.97B 82.39% | 11.44B 11.78% | 12.73B 11.26% | 16.24B 27.53% |
All numbers in INR (except ratios and percentages)